Take2 Technologies Limited et al v. Pacific Biosciences of California, Inc.

  1. March 25, 2024

    PacBio CEO's Words Haunt Patent Invalidity Arguments

    A California federal judge concluded Monday that statements made by the chief executive officer of biotech company Pacific Biosciences to investors at an earnings call undermined the company's invalidity arguments in a patent suit it's facing.

  2. December 04, 2023

    PacBio Sees Most Of Its In-House Legal Dept. DQ'd In IP Row

    A California federal judge on Monday disqualified all but one of Pacific Biosciences' in-house attorneys and legal support staff from working on a patent infringement case against the biotechnology company, adopting PacBio's proposed measures after the judge disqualified a former Perkins Coie LLP attorney last month.

  3. November 06, 2023

    Ex-Perkins Coie Atty DQ'd From Defending PacBio In IP Fight

    A California federal judge on Monday disqualified a former Perkins Coie LLP attorney, now working in-house at Pacific Biosciences of California Inc., from helping out with a patent infringement case against the biotechnology company, though the judge declined to disqualify the entire in-house legal team as was requested.